Showing results (181-190 of 310) with videos related to
Sort By:
Pageof 31
Medicine|July 1, 1978
Membranous nephropathy in patients with rheumatoid arthritis: relationship to gold therapyB Samuels, J C Lee, E P Engleman, et al.Diabetes Care|July 1, 1993
Obesity, diabetes, and hyperlipidemia in a central Australian aboriginal community with a long history of acculturationK O'Dea, M Patel, D Kubisch, et al.Journal of Hypertension. Supplement : Official Journal of the International Society of Hypertension|March 1, 1990
Simvastatin in the treatment of hypercholesterolaemia in patients with essential hypertensionT Morgan, A Anderson, P McDonald, et al.Biochimica Et Biophysica Acta|December 18, 1981
Characterization of glycosaminoglycans in urine from patients with nephrotic syndrome and control subjects, and their effects on lipoprotein lipaseI Staprans, S J Garon, J Hopper, et al.Kidney International|January 4, 1998
Renal microvascular injury induced by antibody to glomerular endothelial cells is mediated by C5b-9M Nangaku, C E Alpers, J Pippin, et al.Kidney International|July 28, 2001
Osteopontin expression in human cyclosporine toxicityK L Hudkins, Q C Le, S Segerer, et al.The American Journal of Pathology|January 1, 1991
Urinary excretion of the C5b-9 membrane attack complex of complement is a marker of immune disease activity in autologous immune complex nephritisC J Pruchno, M M Burns, M Schulze, et al.Circulation|August 26, 1998
Comparison of apolipoprotein and proteoglycan deposits in human coronary atherosclerotic plaques: colocalization of biglycan with apolipoproteinsK D O'Brien, K L Olin, C E Alpers, et al.Kidney International|February 1, 1996
Role of the complement membrane attack complex (C5b-9) in mediating experimental mesangioproliferative glomerulonephritisJ Brandt, J Pippin, M Schulze, et al.Kidney International|March 1, 1995
Cellular events in the evolution of experimental diabetic nephropathyB A Young, R J Johnson, C E Alpers, et al.Pageof 31